{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["16"],"submitter":["Xu W"],"pubmed_abstract":["<h4>Aim</h4>To explore clinical features and prognosis of hepatocellular carcinoma (HCC) in hepatitis B virus surface antigen (HBsAg)-serocleared patients and identify risk factors associated with postoperative recurrence after curative hepatectomy.<h4>Methods</h4>Patients who had undergone initial hepatectomy for HCC from January 2010 through December 2022. Clinicopathological data were compared between HBsAg-seropositive and HBsAg-serocleared patients. Furthermore, risk factors associated with early and late postoperative HCC recurrence (early and late recurrences (ER and LR), respectively) were analyzed for HBsAg-serocleared HCC patients treated by curative hepatectomy.<h4>Results</h4>A total of 2184 consecutive patients undergoing initial hepatectomy for HCC were enrolled, including 33"],"journal":["Therapeutic advances in medical oncology"],"pagination":["17588359241289202"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11526261"],"repository":["biostudies-literature"],"pubmed_title":["Hepatocellular carcinoma in HBsAg seroclearance: clinical features, recurrence, and prognosis following curative hepatectomy."],"pmcid":["PMC11526261"],"pubmed_authors":["Yin X","Li B","Xu W","Gong H"],"additional_accession":[]},"is_claimable":false,"name":"Hepatocellular carcinoma in HBsAg seroclearance: clinical features, recurrence, and prognosis following curative hepatectomy.","description":"<h4>Aim</h4>To explore clinical features and prognosis of hepatocellular carcinoma (HCC) in hepatitis B virus surface antigen (HBsAg)-serocleared patients and identify risk factors associated with postoperative recurrence after curative hepatectomy.<h4>Methods</h4>Patients who had undergone initial hepatectomy for HCC from January 2010 through December 2022. Clinicopathological data were compared between HBsAg-seropositive and HBsAg-serocleared patients. Furthermore, risk factors associated with early and late postoperative HCC recurrence (early and late recurrences (ER and LR), respectively) were analyzed for HBsAg-serocleared HCC patients treated by curative hepatectomy.<h4>Results</h4>A total of 2184 consecutive patients undergoing initial hepatectomy for HCC were enrolled, including 33","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024","modification":"2025-04-26T17:02:26.719Z","creation":"2025-04-06T15:21:55.639Z"},"accession":"S-EPMC11526261","cross_references":{"pubmed":["39483138"],"doi":["10.1177/17588359241289202"]}}